272 related articles for article (PubMed ID: 26972225)
1. Metabolic syndrome in relation to Barrett's esophagus and esophageal adenocarcinoma: Results from a large population-based case-control study in the Clinical Practice Research Datalink.
Drahos J; Li L; Jick SS; Cook MB
Cancer Epidemiol; 2016 Jun; 42():9-14. PubMed ID: 26972225
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome and risk of esophageal adenocarcinoma in elderly patients in the United States: An analysis of SEER-Medicare data.
Drahos J; Ricker W; Pfeiffer RM; Cook MB
Cancer; 2017 Feb; 123(4):657-665. PubMed ID: 27861759
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome increases risk of Barrett esophagus in the absence of gastroesophageal reflux: an analysis of SEER-Medicare Data.
Drahos J; Ricker W; Parsons R; Pfeiffer RM; Warren JL; Cook MB
J Clin Gastroenterol; 2015 Apr; 49(4):282-8. PubMed ID: 24671095
[TBL] [Abstract][Full Text] [Related]
4. Risk factors in the development of esophageal adenocarcinoma.
Pohl H; Wrobel K; Bojarski C; Voderholzer W; Sonnenberg A; Rösch T; Baumgart DC
Am J Gastroenterol; 2013 Feb; 108(2):200-7. PubMed ID: 23247577
[TBL] [Abstract][Full Text] [Related]
5. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.
Shaheen N; Ransohoff DF
JAMA; 2002 Apr; 287(15):1972-81. PubMed ID: 11960540
[TBL] [Abstract][Full Text] [Related]
6. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
[TBL] [Abstract][Full Text] [Related]
7. Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinoma.
Wennerström EC; Risques RA; Prunkard D; Giffen C; Corley DA; Murray LJ; Whiteman DC; Wu AH; Bernstein L; Ye W; Chow WH; Vaughan TL; Liao LM
Cancer Med; 2016 Sep; 5(9):2657-65. PubMed ID: 27384379
[TBL] [Abstract][Full Text] [Related]
8. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori Infection Is Associated With Reduced Risk of Barrett's Esophagus: An Analysis of the Barrett's and Esophageal Adenocarcinoma Consortium.
Wang Z; Shaheen NJ; Whiteman DC; Anderson LA; Vaughan TL; Corley DA; El-Serag HB; Rubenstein JH; Thrift AP
Am J Gastroenterol; 2018 Aug; 113(8):1148-1155. PubMed ID: 29880962
[TBL] [Abstract][Full Text] [Related]
10. Lack of differential pattern in central adiposity and metabolic syndrome in Barrett's esophagus and gastroesophageal reflux disease.
Healy LA; Ryan AM; Pidgeon G; Ravi N; Reynolds JV
Dis Esophagus; 2010 Jul; 23(5):386-91. PubMed ID: 20353443
[TBL] [Abstract][Full Text] [Related]
11. Gastroesophageal reflux and Barrett's esophagus: a pathway to esophageal adenocarcinoma.
Schlottmann F; Molena D; Patti MG
Updates Surg; 2018 Sep; 70(3):339-342. PubMed ID: 30039277
[TBL] [Abstract][Full Text] [Related]
12. Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus.
Smith KJ; O'Brien SM; Smithers BM; Gotley DC; Webb PM; Green AC; Whiteman DC
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2481-6. PubMed ID: 16284367
[TBL] [Abstract][Full Text] [Related]
13. Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium.
Cook MB; Shaheen NJ; Anderson LA; Giffen C; Chow WH; Vaughan TL; Whiteman DC; Corley DA
Gastroenterology; 2012 Apr; 142(4):744-53. PubMed ID: 22245667
[TBL] [Abstract][Full Text] [Related]
14. A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagus.
Dai JY; de Dieu Tapsoba J; Buas MF; Onstad LE; Levine DM; Risch HA; Chow WH; Bernstein L; Ye W; Lagergren J; Bird NC; Corley DA; Shaheen NJ; Wu AH; Reid BJ; Hardie LJ; Whiteman DC; Vaughan TL
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1739-47. PubMed ID: 26377193
[TBL] [Abstract][Full Text] [Related]
15. Does physical activity protect against the development of gastroesophageal reflux disease, Barrett's esophagus, and esophageal adenocarcinoma? A review of the literature with a meta-analysis.
Lam S; Hart AR
Dis Esophagus; 2017 Nov; 30(11):1-10. PubMed ID: 28881908
[TBL] [Abstract][Full Text] [Related]
16. Ghrelin and Leptin Have a Complex Relationship with Risk of Barrett's Esophagus.
Thomas SJ; Almers L; Schneider J; Graham JE; Havel PJ; Corley DA
Dig Dis Sci; 2016 Jan; 61(1):70-9. PubMed ID: 26396004
[TBL] [Abstract][Full Text] [Related]
17. LOW PREVALENCE OF BARRETT'S ESOPHAGUS IN A RISK AREA FOR ESOPHAGEAL CANCER IN SOUTH OF BRAZIL.
DE Carli DM; Araujo AF; Fagundes RB
Arq Gastroenterol; 2017 Dec; 54(4):305-307. PubMed ID: 28954045
[TBL] [Abstract][Full Text] [Related]
18. Adiponectin May Modify the Risk of Barrett's Esophagus in Patients With Gastroesophageal Reflux Disease.
Almers LM; Graham JE; Havel PJ; Corley DA
Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2256-64.e1-3. PubMed ID: 25632808
[TBL] [Abstract][Full Text] [Related]
19. [Gastroesophageal reflux disease and malignancy].
Richert Z; Robaszkiewicz M
Rev Prat; 2008 Sep; 58(13):1414-5, 1417, 1419-20. PubMed ID: 18924321
[TBL] [Abstract][Full Text] [Related]
20. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
